Treatment of non-small cell lung cancer: new cytostatic agents
- 1 December 1993
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 10 (3) , 173-187
- https://doi.org/10.1016/0169-5002(93)90178-z
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Fotemustine: French multicenter phase II study in 67 patients with advanced non small cell lung carcinoma (NSCLC)Lung Cancer, 1991
- Management of non-small cell and small cell lung cancerCurrent Opinion in Oncology, 1991
- Chemotherapy in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Phase II study of (glycolate-O,O′) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 1990
- TCNU in adenocarcinoma of the lung: A Phase II study with divided dosesAnnals of Oncology, 1990
- A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1989
- Phase II study of pirarubicin in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Randomized Phase II Evaluation of Iproplatin (CHIP) and Carboplatin (CBDCA) in Lung CancerAmerican Journal of Clinical Oncology, 1988
- Phase II trial of 4′‐deoxydoxorubicin (DxDx) in non‐small cell lung cancer: A cancer and leukemia group B trialMedical and Pediatric Oncology, 1988
- TNO6 in non small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1987